View in EDS HTML Full Text PDF Full Text

Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review.

Saved in:
Bibliographic Details
Title: Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review.
Authors: Ogiya D; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan. giyapen1106@gmail.com., Suzuki R; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Goto S; Division of Postgraduate Education, Tokai University School of Medicine, Isehara, Japan., Nakagawa Y; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan., Nasukawa M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Iwata S; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Kawai H; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Toyosaki M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Machida S; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Ogawa Y; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan., Kawada H; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Source: Annals of hematology [Ann Hematol] 2025 Nov; Vol. 104 (11), pp. 6075-6079. Date of Electronic Publication: 2025 Oct 29.
Publication Type: Case Reports; Journal Article; Review
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41152534
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ogiya+D%22">Ogiya D</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan. giyapen1106@gmail.com.<br /><searchLink fieldCode="AU" term="%22Suzuki+R%22">Suzuki R</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Goto+S%22">Goto S</searchLink>; Division of Postgraduate Education, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Nakagawa+Y%22">Nakagawa Y</searchLink>; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Nasukawa+M%22">Nasukawa M</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Iwata+S%22">Iwata S</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Kawai+H%22">Kawai H</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Toyosaki+M%22">Toyosaki M</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Machida+S%22">Machida S</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Onizuka+M%22">Onizuka M</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Ogawa+Y%22">Ogawa Y</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.<br /><searchLink fieldCode="AU" term="%22Kawada+H%22">Kawada H</searchLink>; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2025 Nov; Vol. 104 (11), pp. 6075-6079. <i>Date of Electronic Publication: </i>2025 Oct 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41152534
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-025-06689-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6075
    Titles:
      – TitleFull: Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ogiya D
      – PersonEntity:
          Name:
            NameFull: Suzuki R
      – PersonEntity:
          Name:
            NameFull: Goto S
      – PersonEntity:
          Name:
            NameFull: Nakagawa Y
      – PersonEntity:
          Name:
            NameFull: Nasukawa M
      – PersonEntity:
          Name:
            NameFull: Iwata S
      – PersonEntity:
          Name:
            NameFull: Kawai H
      – PersonEntity:
          Name:
            NameFull: Toyosaki M
      – PersonEntity:
          Name:
            NameFull: Machida S
      – PersonEntity:
          Name:
            NameFull: Onizuka M
      – PersonEntity:
          Name:
            NameFull: Ogawa Y
      – PersonEntity:
          Name:
            NameFull: Kawada H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0584
          Numbering:
            – Type: volume
              Value: 104
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1